Viscosupplementation: Global Market Overview

Report Scope:

The current report offers a detailed picture of the viscosupplementation market. Viscosupplementation is indicated for the treatment of knee, hip, shoulder and ankle osteoarthritis. Hyaluronic acid viscosupplement is injected into joints to reduce joint pains and treat osteoarthritis.

This report highlights the current and future market potential for viscosupplementation and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as market shares for key market players.

This report details market shares for viscosupplementation based on procedure type, application and geography. Based on procedure type, the market is segmented into Three-Injection cycle, Single-Injection cycle and Five-Injection cycle procedure segments. Based on the application, the market is segmented into knee osteoarthritis, hip osteoarthritis, and the others segment.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for the year 2018 as the base year, with forecasts for 2019 Through 2025. Estimated values are based on viscosupplement manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

The Report Includes:

39 tables
An overview of global viscosupplementation market
Detailed market share of viscosupplementation based on product type, procedure type, injection cycle, and application
Highlights of current and future market potential of viscosupplementation and a detailed analysis of the competitive environment, regulatory scenario, patent analysis, and drivers, challenges, and trends in market growth
Knowledge about hyaluronic acid, a lubricating agent and discussion on how it enables smooth movement of bones
Coverage of minimally invasive viscosupplementation procedures, new product innovations, and rapid product advancements
Insights into strategic initiatives by major companies including partnerships, agreements, geographic expansions, R&D of products, new product launches, mergers and acquisitions and opportunities for the companies
Company profiles of major global corporations within this market, including Anika Therapeutics Inc., Bioventus, Chugai Pharmaceuticals Co., Ltd., Sanofi and Seikagaku Corp.

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Osteoarthritis
Etiology
Epidemiology and Market Burden
Prevalence of Osteoarthritis
Disease Symptoms
Risk Factors
Diagnosis
Treatments
Reducing the Risk of Osteoarthritis

Chapter 4 Market Dynamics

Market Drivers
Increasing Prevalence of Knee Osteoarthritis
Growing Elderly Population
Emerging Countries
Minimally Invasive Procedures
Market Restraints
Substitute Treatment Options
Intellectual Property
Insurance Denials
Government Regulations
Market Opportunities
Patient Preference
Strategic Initiatives
New Product Launches and R&D

Chapter 5 Market Breakdown by Procedure Type

Global Market for Viscosupplementation by Procedure Type
Three-Injection Cycle
Market Size and Forecast
Single-Injection Cycle
Market Size and Forecast
Five-Injection Cycle
Market Size and Forecast

Chapter 6 Market Breakdown by Application

Global Market for Viscosupplementation by Application
Knee Osteoarthritis
Market Size and Forecast
Hip Osteoarthritis
Market Size and Forecast
Other Applications (Shoulder and Ankle Osteoarthritis)
Market Size and Forecast

Chapter 7 Market Breakdown by Region

Global Market for Viscosupplementation by Region
North America
United States
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
Latin America
Market Size and Forecast
Market Analysis
Middle East and Africa
Market Size and Forecast
Market Analysis

Chapter 8 Regulatory Structure: Medical Devices

Regulatory Background
Regulation of Medical Devices by Country/Region
U.S.
European Union (EU)
Japan

Chapter 9 Competitive Landscape

Global Company Market Share Analysis
Mergers and Acquisitions
Agreements, Contracts, Collaborations and Partnerships
New Product Launches

Chapter 10 Company Profiles

Major Viscosupplement Manufacturers
Anika Therapeutics Inc.
Bioventus
Chugai Pharmaceutical Co., Ltd.
Ferring B.V.
Fidia Farmaceutici S.P.A.
Sanofi
Seikagaku Corp.
Other Prominent Companies

Chapter 11 Appendix: Acronyms

List of Tables

Summary Table A: Global Market for Viscosupplementation, by Procedure Type, Through 2025
Summary Table B: Global Market for Viscosupplementation, by Application, Through 2025
Table 1: Global Prevalence of Osteoarthritis (Symptomatic), by Region/Country, Through 2018
Table 2: Prevalence of Obesity in Males and Females in Australia, 1995-2015
Table 3: Global Market for Viscosupplementation, by Procedure Type, Through 2025
Table 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 5: Global Market for Single-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 6: Global Market for Five-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 7: Global Market for Viscosupplementation, by Application, Through 2025
Table 8: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, Through 2025
Table 9: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, Through 2025
Table 10: Global Market for Other Applications in Viscosupplementation, by Region, Through 2025
Table 11: Global Market for Viscosupplementation, by Region, Through 2025
Table 12: North American Market for Viscosupplementation, by Procedure Type, Through 2025
Table 13: North American Market for Viscosupplementation, by Country, Through 2025
Table 14: European Market for Viscosupplementation, by Sub-Region, Through 2025
Table 15: European Market for Viscosupplementation, by Procedure Type, Through 2025
Table 16: Western European Market for Viscosupplementation, by Country, Through 2025
Table 17: Asia-Pacific Market for Viscosupplementation, by Procedure Type, Through 2025
Table 18: Asia-Pacific Market for Viscosupplementation, by Country, Through 2025
Table 19: Latin American Market for Viscosupplementation, by Procedure Type, Through 2025
Table 20: Middle Eastern and African Market for Viscosupplementation, by Procedure Type, Through 2025
Table 21: Regulatory Approval: U.S. versus Europe
Table 22: Global Market Analysis of Viscosupplements, by Company, 2018
Table 23: Recent Product Launches: Viscosupplementation Market, 2016-2019
Table 24: Recent Product Approvals in the Viscosupplementation Market, 2015-2020
Table 25: Anika Therapeutics Inc.: Revenue, 2016-2018
Table 26: Anika Therapeutics Inc.: Viscosupplement Products, 2018
Table 27: Bioventus: Viscosupplement Products, 2018
Table 28: Chugai Pharmaceutical Co., Ltd.: Revenue, 2016-2018
Table 29: Chugai Pharmaceutical Co., Ltd.: Viscosupplement Products, 2018
Table 30: Ferring B.V.: Revenue, 2016-2018
Table 31: Ferring B.V.: Viscosupplement Products, 2018
Table 32: Fidia Farmaceutici S.p.A.: Viscosupplement Products, 2018
Table 33: Sanofi: Revenue, 2016-2018
Table 34: Sanofi: Viscosupplement Products, 2018
Table 35: Seikagaku Corp.: Revenue, 2016-2018
Table 36: Seikagaku Corp.: Viscosupplement Products, 2018
Table 37: Other Prominent Companies in the Viscosupplementation Market
Table 38: Acronyms Used in This Report

List of Figures

Summary Figure A: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
Summary Figure B: Global Market Shares for Viscosupplementation, by Application, 2018
Figure 1: Prevalence of Adult Obesity in Selected Countries, 2016
Figure 2: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 3: Global Market for Three-Injection Cycle Viscosupplementation, 2017-2025
Figure 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 5: Global Market for Single-Injection Cycle Viscosupplementation, 2017-2025
Figure 6: Global Market for Single-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 7: Global Market for Five-Injection Cycle Viscosupplementation, 2017-2025
Figure 8: Global Market for Five-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 9: Global Market Shares for Viscosupplementation, by Application, 2018
Figure 10: Global Market for Knee Osteoarthritis Viscosupplementation, 2017-2025
Figure 11: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, 2017-2025
Figure 12: Global Market for Hip Osteoarthritis Viscosupplementation, 2017-2025
Figure 13: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, 2017-2025
Figure 14: Global Market for Other Applications in Viscosupplementation, 2017-2025
Figure 15: Global Market for Other Applications in Viscosupplementation, by Region, 2017-2025
Figure 16: Global Market Shares for Viscosupplementation, by Region, 2018
Figure 17: North American Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 18: North American Market Shares for Viscosupplementation, by Country, 2018
Figure 19: U.S. Market for Viscosupplementation, 2017-2025
Figure 20: Canadian Market for Viscosupplementation, 2017-2025
Figure 21: European Market Shares for Viscosupplementation, by Region, 2018
Figure 22: European Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 23: Western European Market Shares for Viscosupplementation, by Country, 2018
Figure 24: UK Market for Viscosupplementation, 2017-2025
Figure 25: German Market for Viscosupplementation, 2017-2025
Figure 26: French Market for Viscosupplementation, 2017-2025
Figure 27: Italian Market for Viscosupplementation, 2017-2025
Figure 28: Spanish Market for Viscosupplementation, 2017-2025
Figure 29: Rest of Western European Market for Viscosupplementation, 2017-2025
Figure 30: Eastern European Market for Viscosupplementation, 2017-2025
Figure 31: Asia-Pacific Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 32: Asia-Pacific Market Shares for Viscosupplementation, by Country, 2018
Figure 33: Japanese Market for Viscosupplementation, 2017-2025
Figure 34: Chinese Market for Viscosupplementation, 2017-2025
Figure 35: Indian Market for Viscosupplementation, 2017-2025
Figure 36: Australian Market for Viscosupplementation, 2017-2025
Figure 37: South Korean Market for Viscosupplementation, 2017-2025
Figure 38: Rest of Asia-Pacific Market for Viscosupplementation, 2017-2025
Figure 39: Latin American Market for Viscosupplementation, 2017-2025
Figure 40: Latin American Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 41: Middle Eastern and African Market for Viscosupplementation, 2017-2025
Figure 42: Middle Eastern and African Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 43: Global Market Shares for Viscosupplementation, by Major Manufacturer, 2018
Figure 44: Anika Therapeutics Inc.: Revenue Share, by Region, 2018
Figure 45: Anika Therapeutics Inc.: Revenue Share, by Business Segment, 2018
Figure 46: Anika Therapeutics Inc.: Orthobiologics Segment Sales Revenue, 2015-2018
Figure 47: Anika Therapeutics Inc.: R&D Expenditures, 2015-2018
Figure 48: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Region, 2018
Figure 49: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Business Segment, 2018
Figure 50: Chugai Pharmaceutical Co., Ltd.: Sales Revenue from Suvenyl, 2015-2018
Figure 51: Chugai Pharmaceutical Co., Ltd.: R&D Expenditures, 2015-2018
Figure 52: Ferring B.V.: Revenue Share, by Region, 2018
Figure 53: Ferring B.V.: R&D Expenditures, 2017 and 2018
Figure 54: Sanofi: Revenue Share, by Region, 2018
Figure 55: Sanofi: Revenue Share, by Business Segment, 2018
Figure 56: Sanofi: Sales Revenue from Synvisc/Synvisc-One, 2015-2018
Figure 57: Sanofi: R&D Expenditures, 2015-2018
Figure 58: Seikagaku Corp.: Revenue Share, by Region, 2018
Figure 59: Seikagaku Corp.: Revenue Share, by Business Segment, 2018
Figure 60: Seikagaku Corp.: Sales Revenue from Gel-One, Visco-3, and Supartz, 2015-2018
Figure 61: Seikagaku Corp.: R&D Expenditures, 2015-2018

Samples

LOADING...

Executive Summary

Growth of the global market is attributed to the growing prevalence of knee osteoarthritis, a strong product pipeline for single and Three-Injection cycle market segments and strong investment into research and development activities by key market players, including Seikagaku Corp., Anika Therapeutics Inc., Bioventus, Fidia Farmaceutici, and others.

Increasing patient preference for new, minimally-invasive viscosupplementation procedures comes with a substantial increase in the prevalence of knee osteoarthritis in the U.S.

The U.S. is one of the major markets for viscosupplements. According to the U.S. Arthritis Foundation, osteoarthritis is the most common type of arthritis. It affects nearly 30 million people in the U.S. The increased number of osteoarthritis patients is likely to drive the market for viscosupplementation during the forecast period.

The global viscosupplementation market is segmented in this report by procedure type, application, and region.

Companies Mentioned

Anika Therapeutics Inc.
Bioventus
Chugai Pharmaceutical Co., Ltd.
Ferring B.V.
Fidia Farmaceutici S.P.A.
Sanofi
Seikagaku Corp.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1333EUR$1,375USD£1,141GBP €2665EUR$2,750USD£2,283GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€1599EUR$1,650USD£1,370GBP €3198EUR$3,300USD£2,739GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€1919EUR$1,980USD£1,643GBP €3838EUR$3,960USD£3,287GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2303EUR$2,376USD£1,972GBP €4605EUR$4,752USD£3,944GBP

Table of Contents

Samples

Executive Summary

Companies Mentioned

Related Topics

Related Reports

Viscosupplementation Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

Viscosupplementation Global Market Report 2024

Global Viscosupplementation Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Global Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Forecast 2023-2030

Viscosupplementation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)